Research Alliance Corp. II
Index- P/E- EPS (ttm)-0.04 Insider Own3.23% Shs Outstand19.19M Perf Week-0.51%
Market Cap186.91M Forward P/E- EPS next Y- Insider Trans0.00% Shs Float14.95M Perf Month-0.20%
Income-0.70M PEG- EPS next Q- Inst Own92.60% Short Float0.01% Perf Quarter-1.42%
Sales- P/S- EPS this Y- Inst Trans-0.09% Short Ratio0.02 Perf Half Y-9.06%
Book/sh7.56 P/B1.29 EPS next Y- ROA-0.50% Target Price- Perf Year-
Cash/sh0.04 P/C233.64 EPS next 5Y- ROE-0.50% 52W Range9.64 - 10.35 Perf YTD-0.31%
Dividend- P/FCF- EPS past 5Y- ROI- 52W High-5.89% Beta-
Dividend %- Quick Ratio5.00 Sales past 5Y- Gross Margin- 52W Low1.04% ATR0.03
Employees- Current Ratio5.00 Sales Q/Q- Oper. Margin- RSI (14)45.96 Volatility0.12% 0.20%
OptionableNo Debt/Eq0.00 EPS Q/Q-866.20% Profit Margin- Rel Volume0.00 Prev Close9.74
ShortableYes LT Debt/Eq0.00 Earnings- Payout- Avg Volume84.14K Price9.74
Recom- SMA20-0.37% SMA50-0.05% SMA200-2.77% Volume2 Change0.00%
Nov-12-21 10:03AM  
May-17-21 08:00AM  
Apr-28-21 09:07AM  
Mar-22-21 02:30PM  
Research Alliance Corp. II does not have significant operations. The company intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. It identifies and acquires a business, focusing on the healthcare industry, such as in biotechnology sector. Research Alliance Corp. II was incorporated in 2020 and is based in Las Vegas, Nevada.